Efficacy and safety of ibuprofen arginine in the treatment of primary dysmenorrhoea

Clinical Drug Investigation

Volumn 24, Issue 7, 2004, Pages 385-393

  Castelo Branco, Camil ^a,e   Casals, Gemma ^a   Haya, Javier ^b   Cancelo, María Jesús ^c   Manasanch, José ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^d Centre d'Immunologie Pierre Fabre   (France)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; IBUPROFEN ARGININE; SAETIL;

ABDOMINAL PAIN; ABSENTEEISM; ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; DYSPEPSIA; EPIGASTRIC PAIN; EVALUATION; EVOLUTION; FEMALE; GASTROINTESTINAL DISEASE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MENORRHAGIA; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; RASH; SCHOOL; SIDE EFFECT; STOMACH PAIN; TIME; TREATMENT OUTCOME; VAGINITIS; VOMITING; WORK;

EID: 3242737284     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424070-00002     Document Type: Article

References (31)

1. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 87: 55-8
2. Morrison JC, Ling FW, Forman EK, et al. Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea. South Med J 1980; 73 (8): 999-1002
3. Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhea: a systematic review. Br J Obstet Gynaecol 1998; 105 (7): 780-9
4. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982; 144: 655-60
5. Svanberg L, Ulmsten U. The incidence of primary dysmenorrhea in teenagers. Arch Gynecol 1981; 230: 173-7
6. Dawood MY. Dysmenorrhoea. Clin Obstet Gynecol. 1990; 33 (1): 168-78
7. Milsom I, Andersch B. Ibuprofen and naproxen-sodium in the treatment of primary dysmenorrhea: a double-blind cross-over study. Int J Gynaecol Obstet 1985; 34: 305-10
8. Dawood MY. Ibuprofen and dysmenorrhea. Am J Med 1984; 13: 87-94
9. Busson M. Update on ibuprofen: review article. J Int Med Res 1986; 14: 53-62
10. Martin Calero MJ, Jiménez MD, Alarcón de la Lastra C, et al. Protective effect of L-arginine against ibuprofen-induced gastric injury rats. Pharm Sci 1997; 3: 609-12
11. Ceppi Monti G, Gazzaniga A, Gianisello V, et al. Activity and pharmacokinetics of a new oral form of soluble ibuprofen. Arzneimittelforschung 1992; 42 (4): 556-69
12. Sandrini G, Franchini S, Lanfranchini S, et al. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. Int J Clin Pharmacol Res 1998; 18 (3): 145-50
13. Rodríguez MJ. Eficacia analgésica y tolerabilidad de ibuprofen-arginina en el dolor del raquis: resultados de un estudio multicéntrico. Rev Soc Esp Dolor 1996; 3: 1-4
14. Manso FJ, Bascones A, Maqueda MJ, et al. Estudio controlado sobre la eficacia y tolerabilidad de ibuprofen-arginina vs aceclofenaco en el control del dolor post-extracción quirúrgica de molares inferiores. Av Odontoestomato 1996; 12 (8): 531-6
15. Dawood MY. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am J Med 1988; 84: 23-9
16. Petersen KL, Brennun J, Dahl JB. Experimental evaluation of the analgesic effect of ibuprofen on primary and secondary hyperalgesia. Pain 1997; 70: 167-74
17. Jurna I, Brune K. Central effect of the NSAI agents indomethacin, ibuprofen and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus. Pain 1990; 41 (1): 71-80
18. Kellstein DE, Waksman JA, Furey SA, et al. The safety profile of non-prescription ibuprofen in multiple-dose use: a meta-analysis. J Clin Pharmacol 1999; 39: 520-32
19. Fraser IS, McCarron G. Ibuprofen is a useful treatment for primary dysmenorrhoea. Aust N Z J Obstet Gynaecol 1987; 27: 244-7
20. Marchim M, Tozzi L, Bakshi R, et al. Comparative efficacy of diclofenac dispersible 50mg and ibuprofen 400mg in patients with primary dysmenorrhea. Int J Clin Pharmacol Ther 1995; 33 (9): 491-7
21. Desjardins P, Black P, Papageorge M, et al. Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol 2002; 58 (6): 387-94
22. Moore N, Van Ganse E, Le Parc J-M, et al. The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. Clin Drug Invest 1999; 18 (2): 89-98
23. Henry D, Lim LLY, Garcia LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563-6
24. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual anti-inflammatory drugs. Lancet 1994; 343: 1075-8
25. Wallace JL, Reuter B, Cicala C, et al. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994; 107: 173-9
26. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-16
27. Tana AS, Dahill S, Morran C. Neutrophils, Helicobacter pylori and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 1999; 116: 254-8
28. Mehlisch DR, Ardia A, Pallotta T. A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Parmacol 2002; 42: 904-11
29. Black P, Max MB, Desjardins P, et al. A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther 2002; 24 (7): 1072-89
30. Ridell A, Fitch MI. Patients' knowledge of and attitudes toward the management of cancer pain. Oncol Nurs Forum 1997; 24 (10): 1775-84
31. De Wit R, van Dam F, Zandbelt L, et al. A pain education program for chronic cancer patients: follow-up results from a randomized controlled trial. Pain 1997; 73 (1): 55-69